To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCL0026 | OL-56 (HO-PEG-Ste) Featured |
OL-56 (HO-PEG-Ste) is a hydroxyl-terminated PEG stearate for research on PEG-lipid components of lipid nanoparticles. It combines a PEG chain with a single C18 fatty-acid anchor through an ester linkage.
More description
|
|
| DC31692 | Fludrocortisone Featured |
Fludrocortisone is a synthetic corticosteroid with moderate glucocorticoid potency and much greater mineralocorticoid potency. Therapeutically, it is used for its mineralocorticoid activity and not for its glucocorticoid activity. Fludrocortisone has been used in the treatment of cerebral salt wasting syndrome. However, it is used primarily to replace the missing hormone aldosterone in various forms of adrenal insufficiency such as Addison's disease and the classic salt wasting (21-hydroxylase deficiency) form of congenital adrenal hyperplasia. Due to its effects on increasing Na+ levels, and therefore blood volume, fludrocortisone is the first line of treatment for orthostatic intolerance and postural orthostatic tachycardia syndrome (POTS). It can be used to treat low blood pressure. Fludrocortisone is also used as a confirmation test for diagnosing Conn's syndrome (aldosterone producing-adrenal adenoma).
More description
|
|
| DC68259 | Ki6783 Featured |
|
|
| DC68258 | PPARγ agonist-27 Featured |
PPARγ agonist-27 is an orally active and blood-brain barrier-penetrant PPARγ agonist with EC50 = 4.7 μM. PPARγ agonist-27 activates PPARγ, upregulates downstream Klotho gene expression, and simultaneously inhibits mitochondrial ROS production. PPARγ agonist-27 can be used in research related to neurological diseases such as Alzheimer's disease.
More description
|
|
| DC68257 | 3-((S)-3-aminopiperidin-1-yl)-5-(3,5-dimethylisoxazol-4-yl)-3-phenylindolin-2-one Featured |
|
|
| DC68256 | 2-(5,9-dimethyl-7-oxo-3-phenyl-7H-furo[3,2-g]chromen-6-yl)acetic acid Featured |
|
|
| DC68255 | Lorglumide sodium salt Featured |
Lorglumide sodium (CR-1409 sodium) is an orally active Cholecystokinin Receptor antagonist. Lorglumide sodium inhibits pancreatic cancer cell proliferation, induces G0/G1 phase arrest and apoptosis, and downregulates MMP-2. Lorglumide sodium inhibits gastrin-stimulated Ornithine decarboxylase activity and DNA synthesis, and shows low CCKA/CCKB selectivity. Lorglumide sodium blocks Caerulein (HY-A0190)-induced exocrine pancreatic secretion and pancreatic tissue hyperplastic changes in rats, and inhibits gallbladder emptying induced by exogenous and endogenous CCK in mice.
More description
|
|
| DC68254 | N-(2-((1-methylpyrrolidin-3-yl)oxy)pyridin-3-yl)isonicotinamide hydrochloride Featured |
|
|
| DC68253 | 3-(4-chlorophenyl)-1,6-dimethylpyrimido[5,4-e][1,2,4]triazine-5,7(1H,6H)-dione Featured |
|
|
| DC68252 | (E)-N-(4-oxocyclohexyl)-3-(3,4,5-trimethoxyphenyl)acrylamide Featured |
|
|
| DC68251 | Cinepazide Impurity F Featured |
|
|
| DC68250 | N-Desmethyl Zopiclone Hydrochloride Featured |
|
|
| DC68249 | 4-(3-(1-(4--Cyano-3-(trifluoromethyl)phenyl)methyl-4-oxo-2-thioxo-1,2,3,4-tetrahydroquinazolin-7-yl)-4,4-dimethyl-5-oxo-2-thioxoimidazolidin-1-yl)-2-(trifluoromethyl)benzonitrile Featured |
|
|
| DC68248 | DCN1-IN-2 Featured |
DCN1-IN-2 is a DCN1 inhibitor with an IC50 value of 2.96 nM. DCN1-IN-2 can alleviate Ang II/TGFβ-induced activation of cardiac fibroblasts.
More description
|
|
| DC68247 | 6a-hydroxy-3-(2-hydroxy-5-methylphenyl)-5-(tetrahydro-2H-pyran-4-yl)-4-(4-(trifluoromethyl)phenyl)-3a,4,5,6a-tetrahydropyrrolo[3,4-c]pyrazol-6(1H)-one Featured |
|
|
| DC68246 | N-((8-hydroxyquinolin-7-yl)(p-tolyl)methyl)pentanamide Featured |
|
|
| DC68245 | D359-0396 Featured |
D359-0396 is an orally active NLRP3 inflammasome inhibitor. D359-0396 inhibits pyroptosis and IL-1β release in macrophages. D359-0396 also inhibits the oligomerization of NLRP3, ASC and the cleavage of GSDMD.
More description
|
|
| DC68243 | Atrazine-desethyl Featured |
Atrazine-desethyl is a triazine herbicide.
More description
|
|
| DC68244 | 6-(4-isopropylphenyl)-7,9-dimethyl-11-phenyl-6,7-dihydropyrimido[4',5':3,4]pyrrolo[1,2-a]quinoxaline-8,10(5H,9H)-dione Featured |
|
|
| DC68242 | (E)-6-(4-(4-ethylphenyl)but-1-en-1-yl)-2,3-dihydro-1H-inden-1-one Featured |
|
|
| DC71057 | Indoramin Featured |
Indoramin is an orally active antihypertensive agent. Indoramin is also selective for the α1A-adrenoceptor.
More description
|
|
| DC43294 | PF-429242 dihydrochloride Featured |
Novel subtilisin kexin isozyme-1/site-1 (SKI-1/S1P) protease inhibitor
More description
|
|
| DC10951 | MPT0E028 Featured |
MPT0E028 is a potent HDAC inhibitor that inhibits nuclear HDAC activity with IC50 of 11.1 nM in HeLa cells, 9-30 times more potent than SAHA.
More description
|
|
| DC21023 | FQI1 Featured |
FQI1 is a small-molecule inhibitor of transcription factor LSF with IC50 of 2.1 uM.
More description
|
|
| DC46017 | Zenarestat Featured |
Zenarestat is a potent and orally active aldose reductase inhibitor. Zenarestat improves diabetic peripheral neuropathy in Zucker diabetic fatty rats.
More description
|
|
| DC76159 | MG-C-30 Featured |
MG-C-30 is an orally active agonist for CD27 with an EC50 of 0.84 μM. MG-C-30 activates NK cells and T cell co-stimulatory signals, and enhances immune response. MG-C-30 exhibits antitumor efficacy in mouse EG7-OVA model.
More description
|
|
| DC46983 | Ziconotide acetate Featured |
Ziconotide acetate (SNX-111 acetate), a peptide, is a potent and selective block of N-type calcium channels antagonist. Ziconotide acetate reduces synaptic transmission, and can be used for chronic pain research.
More description
|
|
| DCC5609 | Ziconotide Polyacetate Featured |
Atypical analgesic agent for the amelioration of severe and chronic pain
More description
|
|
| DC81449 | Retro-1 Featured |
Retro-1 is a toxin inhibitor. Retro-1 blocks the retrograde transport of STxB to the trans-Golgi network/Golgi. Retro-1 inhibits the cytotoxic effects of Ricin, bacterial toxins Stx1 and Stx2. Retro-1 can also substantially enhance the effectiveness of antisense and splice switching oligonucleotides.
More description
|
|
| DCC3323 | Methylene Quinuclidinone Featured |
Metablite of PRIMA-1 and APR-246, covalently binding to cysteine residues in mutant p53 and wild type p53, and being increased in unfolded p53, inducing massive apoptosis in p53 null tumor cells
More description
|
|